Related Articles
A novel prednisone premedication protocol significantly decreases infusion‑related reactions of rituximab in newly diagnosed diffuse large B‑cell lymphoma
Central nervous system involvement in adult patients with diffuse large B-cell lymphoma: Influence of rituximab
Rituximab purging and maintenance therapy combined with autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone